chemical structure semaglutide molecule molecule, illustration - Stock Image - F043/1273 Crystal structure of the semaglutide

[UPDATED MONTHLY: MOAA's TRICARE Toolkit] For both Wegovy and Zepbound, TRICARE prior authorization requires adult patients to: Have a BMI greater than or equal to 30 or a BMI greater than or equal to 27 with additional risk factors (e.g., hypertension, sleep apnea)

To manage symptoms effectively: Start with a low dose and titrate slowly Encourage smaller, low-fat meals Consider changing the dosing schedule or formulation Evaluate other GI causes like gastroparesis if symptoms linger Having regular check-ins helps clinicians identify tolerability issues early and adapt treatment accordingly

Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial

Can I Switch Forms